David Tai
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
Papers in
- Oncology 30
- Cancer Immunotherapy and Biomarkers 12
- Pancreatic and Hepatic Oncology Research 8
- Colorectal Cancer Treatments and Studies 5
- Hepatology 29
- Hepatocellular Carcinoma Treatment and Prognosis 26
- Co-authors
- Su Pin Choo (23 shared papers)Valerie Chew (3 shared papers)Joycelyn Jie Xin Lee (15 shared papers)Connie Yip (1 shared paper)Armando Santoro (8 shared papers)Yun Hua Lee (1 shared paper)Brian K. P. Goh (13 shared papers)Pierce K. H. Chow (13 shared papers)
- Journals
- Annals of Oncology (13 papers)Journal of Clinical Oncology (10 papers)Liver Cancer (5 papers)Surgery (4 papers)Cancer Research (3 papers)
- Partner nations
- SingaporeSouth KoreaUnited States
In The Last Decade
David Tai
73 papers receiving 1.6k citations
David Tai's Hit Papers
Peers
Comparison fields: 5 of 78
- Hepatology 449
- Oncology 613
- Immunology 233
- Gastroenterology 51
- Cancer Research 121
Countries citing papers authored by David Tai
This map shows the geographic impact of David Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Tai more than expected).
Fields of papers citing papers by David Tai
This network shows the impact of papers produced by David Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Tai. The network helps show where David Tai may publish in the future.
Co-authors
The 25 scholars most cited alongside David Tai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors Hit paper breakdown → | 2021 | 271 |
| 2 | 2015 | 120 | |
| 3 | 2020 | 105 | |
| 4 | Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC): First results from CheckMate 9DW. Hit paper breakdown → | 2024 | 83 |
| 5 | 2011 | 79 | |
| 6 | 2015 | 74 | |
| 7 | 2021 | 69 | |
| 8 | 2021 | 53 | |
| 9 | 2012 | 46 | |
| 10 | 2010 | 45 | |
| 11 | 2016 | 39 | |
| 12 | 2015 | 37 | |
| 13 | 2024 | 35 | |
| 14 | 2023 | 35 | |
| 15 | 2017 | 30 | |
| 16 | 2019 | 29 | |
| 17 | 2015 | 29 | |
| 18 | 2018 | 29 | |
| 19 | 2020 | 22 | |
| 20 | 2019 | 22 |
About David Tai
David Tai is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Molecular Biology and Surgery, having authored 77 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (26 papers), Cancer Immunotherapy and Biomarkers (12 papers), Pancreatic and Hepatic Oncology Research (8 papers), Fibroblast Growth Factor Research (7 papers), Cancer Genomics and Diagnostics (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Colorectal Cancer Treatments and Studies (5 papers) and Eosinophilic Disorders and Syndromes (5 papers). The work is most often cited by research in Hepatology (449 citations), Oncology (613 citations), Immunology (233 citations), Gastroenterology (51 citations) and Cancer Research (121 citations). David Tai has collaborated with scholars based in Singapore, South Korea and United States. Frequent co-authors include Su Pin Choo, Valerie Chew, Joycelyn Jie Xin Lee, Connie Yip, Armando Santoro, Yun Hua Lee, Brian K. P. Goh, Pierce K. H. Chow, John J. Arcaroli and Keith Wells. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Liver Cancer, Surgery and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.